Effects of Lung Recruitment on Cerebral Hemodynamics(LRCH)
Effects of Lung Recruitment on Cerebral Hemodynamics: a Single-center, Prospective, Randomized-order, Three-period, Self-controlled Design Trial
Patients receiving invasive mechanical ventilation may develop alveolar derecruitment due to atelectasis, secretion retention, changes in body position, or acute respiratory distress syndrome. Lung recruitment maneuvers reopen partially collapsed alveoli by briefly increasing transpulmonary pressure, thereby improving lung volume and oxygenation; however, elevated airway pressure may also affect venous return, mean arterial pressure, and carbon dioxide elimination, and thus alter cerebral blood flow. Therefore, improved oxygenation does not necessarily indicate stable cerebral circulation.
At present, when selecting a lung recruitment modality in clinical practice, clinicians often rely on oxygenation response, respiratory mechanics, and operator experience, while dynamic observation of cerebral hemodynamics remains relatively insufficient. Recording only two time points before and after the maneuver may miss transient but clinically meaningful changes during pressurization, maintenance of high pressure, and recovery. Therefore, under controlled and safe conditions, it is necessary to use three commonly used clinical lung recruitment maneuvers as observational scenarios to describe cerebral hemodynamic changes during lung recruitment and to explore possible physiological factors in conjunction with cardiac output, systemic blood pressure, carbon dioxide, and respiratory mechanics. The findings are expected to provide a physiological basis for bedside cerebral perfusion monitoring and risk identification; however, short-term changes in Vm alone cannot prove that a particular maneuver is safer or improves long-term outcomes.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Xingui Dai, PHD
- 電話番号:18175708210
- メール:20685562@qq.com
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- (1)Age 18 years or older.
- (2)Receiving invasive mechanical ventilation through an endotracheal tube or tracheostomy.
- (3)A clinical indication for a lung recruitment maneuver, with an expectation that three bedside observation periods can be completed during hospitalization.
- (4)An adequate temporal acoustic window for reproducible transcranial Doppler recordings and an adequate echocardiographic window for reproducible left ventricular outflow tract velocity-time integral measurements.
- (5)Axillary temperature between 36.0°C and 37.3°C.
- (6)Written informed consent provided by the participant or a legally authorized representative.
Exclusion Criteria:
- (1)Current use of vasoactive medications.
- (2)Known severe cardiac dysfunction or severe pulmonary hypertension.
- (3)Undrained pneumothorax, marked airflow limitation, giant pulmonary bullae, or another condition associated with a high risk of barotrauma.
- (4)Known markedly elevated intracranial pressure or escalating treatment for intracranial hypertension.
- (5)Any other condition that, in the investigator's judgment, makes participation inappropriate.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Sequence 1: A-B-C
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
|
実験的:Sequence 2: B-C-A
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
|
実験的:Sequence 3: C-A-B
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
|
実験的:Sequence 1: A-C-B
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
|
実験的:Sequence 1: B-A-C
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
|
実験的:Sequence 1: C-B-A
A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them. |
Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later. Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements. Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
mean flow velocity in the middle cerebral artery
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
Middle cerebral artery mean flow velocity (Vm, cm/s) will be measured using transcranial Doppler ultrasonography (TCD). In each study period, measurements will be obtained after at least 10 minutes of stable baseline ventilation. For method A, measurements will be obtained during the final 10 seconds of each 60-second PEEP step and 60 seconds after return to the original ventilation settings. For method B, measurements will be obtained at 35-40 seconds of sustained inflation and 40 seconds after return to the original settings. For method C, measurements will be obtained at baseline and 60 seconds after return to the original settings following the 120-second maneuver. No intra-maneuver TCD measurement is scheduled for method C.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Systolic blood flow velocity (Vs) of the middle cerebral artery
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
The Systolic blood flow velocity (Vs) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
|
diastolic blood flow velocity (Vd) of the middle cerebral artery
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
The diastolic blood flow velocity (Vd) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
|
pulsatility index (PI) of the middle cerebral artery
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
The pulsatility index (PI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
|
resistance index(RI) of the middle cerebral artery
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
The resistance index(RI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
|
Arterial partial pressure of carbon dioxide (PaCO2)
時間枠:Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
PaCO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period. |
Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
|
Arterial partial pressure of oxygen (PaO2)
時間枠:Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
PaO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period. |
Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
|
Arterial blood pH
時間枠:Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
Arterial blood pH will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period. |
Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
|
Arterial blood lactate concentration
時間枠:Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
Arterial blood lactate concentration (mmol/L) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period. |
Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
|
|
Left ventricular outflow tract velocity-time integral (LVOT-VTI)
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
LVOT-VTI (cm) will be measured by Doppler echocardiography at the same prespecified time points as transcranial Doppler measurements in each study period. The measured value and its change from the period-specific pre-maneuver baseline will be reported. For method C, measurements are scheduled only at baseline and during recovery, not during the 120-second maneuver.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
|
End-tidal carbon dioxide (EtCO2)
時間枠:3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
EtCO2 (mmHg) will be monitored by capnography. A valid end-expiratory value will be recorded at the same prespecified time points as the TCD and LVOT-VTI measurements in each study period. The measured value and change from the period-specific baseline will be reported. If no valid expiratory waveform is available at a time point, the value will be recorded as missing.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings. |
3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
|
協力者と研究者
捜査官
- スタディチェア:Xingui Dai PhD, PHD、Chen Zhou NO.1 People's Hospital
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- LRCH-001
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD 共有時間枠
Beginning 6 months after publication of the main study results and available for 3 years.
IPD 共有アクセス基準
Qualified researchers may submit a written request including research purpose, analysis plan, requested data elements, and data protection measures. Requests will be reviewed by the principal investigator and the institution.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。